3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Surgical Wound Infection
2
Neoplasms
2
Sepsis
1
Rectal Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Inflammation
1
Infections
1
Febrile Neutropenia
1
Emergencies
1
Discitis
1
Colorectal Neoplasms
1
Interventions
Meropenem
6
Ceftazidime
5
Vancomycin
4
Ciprofloxacin
3
Cefepime
3
Teicoplanin
2
Levofloxacin
2
Amikacin
2
ceftolozane, tazobactam drug combination
1
Vaccination
1
Tazobactam
1
Simvastatin
1
Pneumococcal Vaccines
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Ofloxacin
1
Micafungin
1
Metronidazole
1
Injections
1
Filgrastim
1
Cilastatin, Imipenem Drug Combination
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Febrile Neutropenia
×
Anti-Bacterial Agents
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled